Physician profile
Andre Nicolas Martinez
NPI 1922503127
$2,636.63
in general payments reported to CMS, 2019-2025
17 companies · $435 in 2025
The $435 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $71.60 · 2021: $598 · 2022: $535 · 2023: $321 · 2024: $676 · 2025: $435.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,432.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,432.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,342.40 | 2021-2025 | Clareon, Ngenuity, Hydrus Microstent |
| Johnson & Johnson Surgical Vision, INC. | $214.63 | 2024 | Tecnis Iol |
| Tarsus Pharmaceuticals, INC. | $170.81 | 2024-2025 | Xdemvy |
| Regeneron Healthcare Solutions, INC. | $155.37 | 2021-2025 | Eylea Hd, Eylea |
| Abbvie INC. | $134.57 | 2024-2025 | |
| Haag-Streit USA, INC. | $115.43 | 2022 | |
| Apellis Pharmaceuticals, INC. | $80.28 | 2023-2025 | Syfovre |
| Biotissue Holdings INC. | $68.08 | 2023 | |
| Dompe US, INC. | $47.37 | 2025 | Oxervate |
| Allergan, INC. | $46.28 | 2021 | |
| New World Medical,INC. | $36.67 | 2023-2025 | Kahook Dual Blade, Streamline, Ahmed Glaucoma Valve |
| Novartis Pharmaceuticals Corporation | $36.64 | 2023 | |
| Sun Pharmaceutical Industries INC. | $36.05 | 2023 | Cequa |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $22.22 | 2021 | |
| Spark Therapeutics, INC. | $20.70 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Halozyme INC | $20.47 | 2024 | Hylenex Recombinant |
| Rayner Intraocular Lenses Limited | $17.06 | 2023 | Rayone Emv, Rayone Spheric, Rayone Aspheric |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andre Martinez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.